Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moderate versus deep rocuronium neuromuscular blockade during laparoscopic gastric bypass
RBR-6g2vcnxCompleted
- Sponsor
- Hospital São Domingos
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of rocuronium in obesity (2 arms), sponsored by Hospital São Domingos. Primary endpoint: Surgical condition quality of the abdominal cavity. Started Oct 2021; status: completed.
02
Drugs
rocuronium
03
Conditions
obesity
Beyond the preview
Go deeper on RBR-6g2vcnx.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6g2vcnx.